CAR T-cell therapy and the management of infectious diseases

On demand webinar

Renowned international experts come together to discuss the challenges and opportunities in the treatment of infections after CAR T-cell therapy. In this on demand webinar we focus on key questions that arise on risk factors for infection, antimicrobial prophylaxis, immunoglobulin supplementation and vaccination. Subsequently a Q&A session takes place, where we will answer questions from the audience. This webinar is a must attend for hematologists, infectiologists and oncologists.Go to video

Speakers

Dr. Marjolein van der Poel

Moderator

Which infections occur, how often does this occur?
What are risk factors for the occurrence of infections? (patient-related factors/CAR-T-related factors, relationship with the occurrence and treatment of CRS/ICANS)
Relationship of emerging infections and hematological and immune recovery after CAR-T

Dr. Joshua Hill

Infectious complications after CAR T-cell therapy

Which infections occur, how often does this occur?
What are risk factors for the occurrence of infections? (patient-related factors/CAR-T-related factors, relationship with the occurrence and treatment of CRS/ICANS)
Relationship of emerging infections and hematological and immune recovery after CAR-T

Dr. Tom van Meerten

Infection prophylaxis

Role of antibacterial prophylaxis
Role of antiviral prophylaxis

Role of antifungal prophylaxis
Monitoring of infections

Prof. Daniel Wolff

Monitoring of immune globulins and role of supplementation/treatment hypogammaglobulinemia

Patient case

Dr. Inger Nijhof

Vaccination after CAR T-cell therapy

Volgt nog!!!

Keep me informed about the accredited e-learning

Register now